ANI Pharmaceuticals Valuation
| BSFA Stock | 52.50 1.00 1.94% |
At this time, the firm appears to be overvalued. ANI Pharmaceuticals shows a prevailing Real Value of USD44.73 per share. The current price of the firm is USD52.5. Our model approximates the value of ANI Pharmaceuticals from reviewing the firm fundamentals such as Profit Margin of (0.24) %, return on equity of -0.26, and Operating Margin of (0.13) % as well as analyzing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that ANI Pharmaceuticals' price fluctuation is very steady at this time. Calculation of the real value of ANI Pharmaceuticals is based on 3 months time horizon. Increasing ANI Pharmaceuticals' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
ANI Pharmaceuticals' intrinsic value may or may not be the same as its current market price of 52.50, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 52.5 | Real 44.73 | Hype 52.5 | Naive 53.28 |
The intrinsic value of ANI Pharmaceuticals' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence ANI Pharmaceuticals' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of ANI Pharmaceuticals helps investors to forecast how ANI stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of ANI Pharmaceuticals more accurately as focusing exclusively on ANI Pharmaceuticals' fundamentals will not take into account other important factors: ANI Pharmaceuticals Total Value Analysis
ANI Pharmaceuticals is currently anticipated to have takeover price of 894.88 M with market capitalization of 699.18 M, debt of 286.52 M, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the ANI Pharmaceuticals fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
894.88 M | 699.18 M | 286.52 M |
ANI Pharmaceuticals Investor Information
About 13.0% of the company shares are held by company insiders. The book value of ANI Pharmaceuticals was currently reported as 19.11. The company recorded a loss per share of 4.46. ANI Pharmaceuticals had not issued any dividends in recent years. Based on the key indicators related to ANI Pharmaceuticals' liquidity, profitability, solvency, and operating efficiency, ANI Pharmaceuticals is not in a good financial situation at the moment. It has a very high risk of going through financial straits in February.ANI Pharmaceuticals Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. ANI Pharmaceuticals has an asset utilization ratio of 28.01 percent. This implies that the Company is making USD0.28 for each dollar of assets. An increasing asset utilization means that ANI Pharmaceuticals is more efficient with each dollar of assets it utilizes for everyday operations.ANI Pharmaceuticals Ownership Allocation
ANI Pharmaceuticals holds a total of 17.45 Million outstanding shares. The majority of ANI Pharmaceuticals outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in ANI Pharmaceuticals to benefit from reduced commissions. Thus, institutional investors are subject to a different set of regulations than regular investors in ANI Pharmaceuticals. Please pay attention to any change in the institutional holdings of ANI Pharmaceuticals as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.ANI Pharmaceuticals Profitability Analysis
The company reported the revenue of 216.14 M. Net Loss for the year was (42.6 M) with profit before overhead, payroll, taxes, and interest of 117.43 M.About ANI Pharmaceuticals Valuation
The stock valuation mechanism determines ANI Pharmaceuticals' current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of ANI Pharmaceuticals based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of ANI Pharmaceuticals. We calculate exposure to ANI Pharmaceuticals's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of ANI Pharmaceuticals's related companies.8 Steps to conduct ANI Pharmaceuticals' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates ANI Pharmaceuticals' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct ANI Pharmaceuticals' valuation analysis, follow these 8 steps:- Gather financial information: Obtain ANI Pharmaceuticals' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine ANI Pharmaceuticals' revenue streams: Identify ANI Pharmaceuticals' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research ANI Pharmaceuticals' industry and market trends, including the size of the market, growth rate, and competition.
- Establish ANI Pharmaceuticals' growth potential: Evaluate ANI Pharmaceuticals' management, business model, and growth potential.
- Determine ANI Pharmaceuticals' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate ANI Pharmaceuticals' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for ANI Stock Analysis
When running ANI Pharmaceuticals' price analysis, check to measure ANI Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ANI Pharmaceuticals is operating at the current time. Most of ANI Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of ANI Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ANI Pharmaceuticals' price. Additionally, you may evaluate how the addition of ANI Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.